Suboptimal vaccination coverage of recommended vaccines among French children with recurrent autoinflammatory fever syndromes: a study from the Juvenile Inflammatory Rheumatism cohort
- 13 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical Rheumatology
- Vol. 40 (7), 2855-2864
- https://doi.org/10.1007/s10067-020-05553-y
Abstract
Introduction/objectives To determine vaccination coverage among a French cohort of children with recurrent autoinflammatory fever syndromes (RFS). Method All RFS children aged 2 to 19 years from the Juvenile Inflammatory Rheumatism cohort and followed at the French Reference Center for Autoinflammatory Diseases, Versailles Hospital, were included in our observational study. Immunisation status at ages 2, 7 and 15 years and at the last outpatient visit was evaluated according to the standard French vaccine schedule and recommended supplementary vaccines for patients with immunosuppressive therapy. Results Of 200 patients, 90 (45%) had periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome; 52 (26%) had familial Mediterranean fever and 50 (25%) had undefined recurrent fever. Complete immunisation as per the standard schedule was obtained by 32% of patients at 2 years, 28% at 7 years, 6% at 15 years and 44% at the last outpatient visit. Similar or higher coverage was obtained by the last outpatient visit for most vaccines, compared to immunisation coverage at 2 years: pneumococcus (91% vs 88%), diphtheria tetanus poliomyelitis (82% vs 86%), hepatitis B (79% vs 69%) and measles, mumps, rubella (91% vs 50%). No patients with immunosuppressive therapy (n = 14) were up to date for all supplementary immunisations recommended for them. Conclusion Vaccination coverage for RFS children is suboptimal, especially for infants who present with recurrent febrile episodes. The initial vaccination delay is partially corrected through specialist follow-up in later years. Coverage according to the supplementary vaccine recommendations for immunosuppressed patients is poor. Key Points • Vaccination coverage for RFS children is suboptimal, especially at 2 years of age which is likely due to the prevalence of early recurrent febrile symptoms. • The initial vaccination delay is partially recovered during later follow-up at an expert rheumatology center. • Specific recommendations are particularly difficult to apply to patients on immunosuppressive therapyThis publication has 38 references indexed in Scilit:
- Vaccination against meningococcus C. vaccinal coverage in the French target populationMedecine Et Maladies Infectieuses, 2013
- Vaccination coverage in children with juvenile idiopathic arthritis followed at a paediatric tertiary care centreRheumatology, 2012
- Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatmentArthritis & Rheumatism, 2012
- Vaccination in paediatric patients with auto-immune rheumatic diseases: A systemic literature review for the European League against Rheumatism evidence-based recommendationsAutoimmunity Reviews, 2011
- Streptococcal hypersensitivity reloaded: severe inflammatory syndrome in Behçet's disease following 23-valent polysaccharide Streptococcus pneumoniae vaccineRheumatology, 2011
- EULAR recommendations for vaccination in paediatric patients with rheumatic diseasesAnnals Of The Rheumatic Diseases, 2011
- Vaccination of children and adolescents with rheumatic diseasesRheumatology, 2011
- ‘ASIA’ – Autoimmune/inflammatory syndrome induced by adjuvantsJournal of Autoimmunity, 2011
- Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and MalignanciesJAMA, 2006
- Frequency of infection in patients with rheumatoid arthritis compared with controls: A population‐based studyArthritis & Rheumatism, 2002